MycoSure is a purpose-orientated South African Food & Bio Tech company on a quest to dramatically improve the food system using the power of mycelium. Mycelium is the root structure of fungi. MycoSure has developed innovative technology to produce mycelium-based protein (myco-protein) using submerged biomass fermentation. Myco-protein is a healthy (high protein, high fibre, and low fat) and highly versatile ingredient with multiple food and beverage applications which can be grown in bioreactors in a few days. Effectively, MycoSure is leveraging a natural process to produce sustainable protein

Phagoflux is developing innovative sensing technology, transforming how it monitors cell health. Its novel approach quantifies autophagic flux, offering a promising avenue to transform healthcare and save lives.

Autophagy, much like regular car maintenance, is a vital intracellular cleaning process that prevents the accumulation of toxic materials within cells. At its core, ‘autophagic flux’ signifies the speed at which these harmful substances are efficiently removed through autophagy. 

Precision medicine, as implemented by Artisan Biomed (a subsidiary of CPGR), involves using 'omics' technologies like genetics and genomics to create personalized healthcare plans. CPGR developed Artisan Biomed to translate advanced genomic research into practical, DNA-based diagnostic and clinical interpretation services in Africa. These services, exemplified by the Mediclinic Precise program, offer tailored approaches for wellness, disease prevention, and health management, particularly in fields like oncology and pharmacogenetics.

South African Astronomy Observatory (SAAO) Network's Southern African Large Telescope (SALT) is upgrading its Robert Stobie Spectrograph (RSS) with a new single monolithic CCD detector to replace the old, fragmented one, improving performance and throughput by eliminating chip gaps and leveraging new fringe-suppression techniques. This new detector will be similar to the one used in the RSS-Red arm, with the goal of being operational by early 2026.